Evidence map›Paper›PMID 26075493›Full record

ArticleChemical research in toxicology2015

Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Chlorpyrifos.

Jaime D'Agostino, Haoming Zhang, Cesar Kenaan, Paul F Hollenberg

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Chlorpyrifos and Chlorpyrifos-Oxon: A Widening Spectrum of Toxicity.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.Journal of environmental science and health. Part C, Toxicology and carcinogenesis · 2021
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jaime D'AgostinoDepartment of Pharmacology, University of Michigan, 2220C MSRB III, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109-5632, United States.
Haoming ZhangDepartment of Pharmacology, University of Michigan, 2220C MSRB III, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109-5632, United States.
Cesar KenaanDepartment of Pharmacology, University of Michigan, 2220C MSRB III, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109-5632, United States.
Paul F HollenbergDepartment of Pharmacology, University of Michigan, 2220C MSRB III, 1150 W. Medical Center Drive, Ann Arbor, Michigan 48109-5632, United States.
University of Michigan–Ann Arbor · US

Funding

ENVIRONMENTAL TOXICOLOGY PRE/POST DOCTORAL RES.TRAININGT32ES007062 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Justin Adam Colacino · 1985 to 2026
$10.5M
TSPO and Neuroinflammation in Alzheimer's DiseaseR01ES007062 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI GUILARTE, TOMAS R · 1995 to 2023
$7.3M
HEMOPROTEIN-CATALYZED OXYGENATIONS OF CARCINOGENSR01CA016954 · NCI · WAYNE STATE UNIVERSITY · PI HOLLENBERG, PAUL F. · 1986 to 2011
$4.3M
HEMOPROTEIN-CATALYZED OXYGENATIONS OF CARCINOGENSR37CA016954 · NCI · WAYNE STATE UNIVERSITY · PI HOLLENBERG, PAUL F. · 1988 to 1995
–
NCI NIH HHS CA16954NCI NIH HHS R01 CA016954NIEHS NIH HHS ES007062NIEHS NIH HHS R01 ES007062NIEHS NIH HHS T32 ES007062
6 · The paper itself

Abstract

Chlorpyrifos (CPS) is a commonly used pesticide which is metabolized by P450s into the toxic metabolite chlorpyrifos-oxon (CPO). Metabolism also results in the release of sulfur, which has been suggested to be involved in mechanism-based inactivation (MBI) of P450s. CYP2B6 was previously determined to have the greatest catalytic efficiency for CPO formation in vitro. Therefore, we characterized the MBI of CYP2B6 by CPS. CPS inactivated CYP2B6 in a time- and concentration-dependent manner with a kinact of 1.97 min(-1), a KI of 0.47 μM, and a partition ratio of 17.7. We further evaluated the ability of other organophosphate pesticides including chorpyrifos-methyl, diazinon, parathion-methyl, and azinophos-methyl to inactivate CYP2B6. These organophosphate pesticides were also potent MBIs of CYP2B6 characterized by similar kinact and KI values. The inactivation of CYP2B6 by CPS was accompanied by the loss of P450 detectable in the CO reduced spectrum and loss of detectable heme. High molecular weight aggregates were observed when inactivated CYP2B6 was run on SDS-PAGE gels indicating protein aggregation. Interestingly, we found that the rat homologue of CYP2B6, CYP2B1, was not inactivated by CPS despite forming CPO to a similar extent. On the basis of the locations of the Cys residues in the two proteins which could react with released sulfur during the metabolism of CPS, we investigated whether the C475 in CYP2B6, which is not conserved in CYP2B1, was the critical residue for inactivation by mutating it to a Ser. CYP2B6 C475S was inactivated to a similar extent as wild type CYP2B6 indicating that C475 is not likely the key difference between CYP2B1 and CYP2B6 with respect to inactivation. These results indicate that CPS and other organophosphate pesticides are potent MBIs of CYP2B6 which may have implications for the toxicity of these pesticides as well as the potential for pesticide-drug interactions.

Indexed as

AnimalsChlorpyrifosChromatography, High Pressure LiquidCytochrome P-450 CYP2B1Cytochrome P-450 CYP2B6Electrophoresis, Polyacrylamide GelHemeHumansInsecticidesKineticsMutagenesis, Site-DirectedProtein BindingRatsSpectrometry, Mass, Electrospray IonizationChlorpyrifosCytochrome P-450 CYP2B1Cytochrome P-450 CYP2B6HemeInsecticides

Identifiers

PMID26075493
PMCPMC6321626
OpenAlexW2403840950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.